I am with you. I followed this stock before the drug approval and was unable to buy it, before the massive run up. Then the management gave their re estimate of their sales and the shares took a dump to $10 to $12 range and I put it again on my monitor list and just a few weeks after that it dropped to under $7. I knew this stock was going to do great, because even in half the estimated sales, this stock was too cheap not to buy. So, I was given my opportunity and I jumped at it. After their sales came out, I started buying more in the $10's, $11's and $12's and $13's. I have a lot more shares in the under $7 shares, but I think this stock is way too cheap. I think even at $40 it is way too cheap. I know this stock and company will do great in the short and long term. It is time to still load up or buy as much as you can afford. We will go much higher and I want to be there. I just hope, nobody tries to buy this in the low $40's.